CUE (STOCKS)
Cue Biopharma, Inc.
$25.800000
+1.270000 (+5.18%)
Prev close: $24.530000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Shao Lee Lin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $107.86M
- Employees
- 41
- P/E (TTM)
- -4.67
- P/B (TTM)
- 3.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $32.73M |
| Benefits Costs and Expenses | -$22.85M |
| Costs And Expenses | $52.50M |
| Nonoperating Income/Loss | $582.00K |
| Operating Expenses | $52.34M |
| Depreciation and Amortization | $1.42M |
| Research and Development | $36.09M |
| Other Operating Expenses | $15.00M |
| Operating Income/Loss | -$19.61M |
| Income/Loss From Continuing Operations After Tax | -$19.52M |
| Income/Loss From Continuing Operations Before Tax | $55.58M |
| Interest Income/Expense After Provision For Losses | -$175.00K |
| Interest Income/Expense Operating, Net | -$175.00K |
| Net Income/Loss | -$19.52M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.52M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.21 |
| Diluted Earnings Per Share | -$1.21 |
| Basic Average Shares | 205,596,940 |
| Diluted Average Shares | 205,596,940 |
| Assets | $30.88M |
| Current Assets | $26.39M |
| Noncurrent Assets | $4.49M |
| Fixed Assets | $288.00K |
| Other Non-current Assets | $4.20M |
| Liabilities | $9.27M |
| Current Liabilities | $7.39M |
| Accounts Payable | $3.33M |
| Other Current Liabilities | $4.06M |
| Noncurrent Liabilities | $1.88M |
| Equity | $21.61M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $21.61M |
| Liabilities And Equity | $30.88M |
| Net Cash Flow From Operating Activities | -$24.46M |
| Net Cash Flow From Operating Activities, Continuing | -$24.46M |
| Net Cash Flow From Investing Activities | $104.00K |
| Net Cash Flow From Investing Activities, Continuing | $104.00K |
| Net Cash Flow From Financing Activities | $27.60M |
| Net Cash Flow From Financing Activities, Continuing | $27.60M |
| Net Cash Flow | $3.24M |
| Net Cash Flow, Continuing | $3.24M |
| Comprehensive Income/Loss | -$19.52M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.52M |
| Other Comprehensive Income/Loss | -$15.93M |